The results commented above may suggest that cross-docking SP and C-terminal α-helices with low nanoMolar affinity children, could be enough to interfere with CSP translation before removal of the SP, despite not targeting any repeats, in contrast to most protective human antibodies. However, some protective activity have been also described for antibodies targeting both Nterminal and repeat sequences .